APIs now comprise nearly three-quarters (71%) of web traffic, posing a significant threat to corporate cybersecurity by expanding the cyber-attack surface, according to Imperva. The security company ...

Teva’s transformation under new CEO Richard Francis is taking another turn. Wednesday, the company confirmed plans to sell its active pharmaceutical ingredients business as part of Francis’ “pivot to ...

The world’s number two producer of active pharmaceutical ingredients (APIs) is for sale. Given the constant global demand for essential medicines, the business might seem like a lucrative asset. But ...

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Workato®, the leading AI-driven enterprise orchestration platform, announced the launch of its Unified API Platform, designed to empower enterprises to publish, ...

Amid rising competition, Teva Pharmaceutical Industries intends to divest its active pharmaceutical ingredients (API) unit to focus on other businesses, including in-house drug development. In 2023, ...

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Boomi™, the intelligent integration and automation leader, today announced the launch of the Boomi API Control Plane — providing enterprises with a centralized ...

TEL AVIV, Israel--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced the appointment of Dr. R. Ananthanarayanan (Ananth) as CEO of its Teva Active ...